The Stuart lab at the Genome Institute of Singapore develops innovative new experimental and computational methods for single-cell genomics.

Through collaborations with clinicians at the Cancer Science Institute of Singapore and Duke-NUS medical school we are applying cutting-edge new methods to study how mutations in epigenomic regulators impact the state of human blood cells in leukemia, lymphoma, or myeloma.

We develop and maintain specialized scientific software for the processing, analysis, interpretation, and visualization of single-cell genomic data.